Sewankambo N, Gray R H, Wawer M J, Paxton L, McNaim D, Wabwire-Mangen F, Serwadda D, Li C, Kiwanuka N, Hillier S L, Rabe L, Gaydos C A, Quinn T C, Konde-Lule J
Makerere University, Kampala, Uganda.
Lancet. 1997 Aug 23;350(9077):546-50. doi: 10.1016/s0140-6736(97)01063-5.
In-vitro research has suggested that bacterial vaginosis may increase the survival of HIV-1 in the genital tract. Therefore, we investigated the association of HIV-1 infection with vaginal flora abnormalities, including bacterial vaginosis and depletion of lactobacilli, after adjustment for sexual activity and the presence of other sexually transmitted diseases (STDs).
During the initial survey round of our community-based trial of STD control for HIV-1 prevention in rural Rakai District, southwestern Uganda, we selected 4718 women aged 15-59 years. They provided interview information, blood for HIV-1 and syphilis serology, urine for detection of Chlamydia trachomatis and Neisseria gonorrhoeae, and two self-administered vaginal swabs for culture of Trichomonas vaginalis and gram-stain detection of vaginal flora, classified by standardised, quantitative, morphological scoring. Scores 0-3 were normal vaginal flora (predominant lactobacilli). Higher scores suggested replacement of lactobacilli by gram-negative, anaerobic microorganisms (4-6 intermediate; 7-8 and 9-10 moderate and severe bacterial vaginosis).
HIV-1 frequency was 14.2% among women with normal vaginal flora and 26.7% among those with severe bacterial vaginosis (p < 0.0001). We found an association between bacterial vaginosis and increased HIV-1 infection among younger women, but not among women older than 40 years; the association could not be explained by differences in sexual activity or concurrent infection with other STDs. The frequency of bacterial vaginosis was similar among HIV-1-infected women with symptoms (55.0%) and without symptoms (55.7%). The adjusted odds ratio of HIV-1 infection associated with any vaginal flora abnormality (scores 4-10) was 1.52 (95% CI 1.22-1.90), for moderate bacterial vaginosis (scores 7-8) it was 1.50 (1.18-1.89), and for severe bacterial vaginosis (scores 9-10) it was 2.08 (1.48-2.94).
This cross-sectional study cannot show whether disturbed vaginal flora increases susceptibility to HIV-1 infection. Nevertheless, the increased frequency of HIV-1 associated with abnormal flora among younger women, for whom HIV-1 acquisition is likely to be recent, but not among older women, in whom HIV-1 is likely to have been acquired earlier, suggests that loss of lactobacilli or presence of bacterial vaginosis may increase susceptibility to HIV-1 acquisition. If this inference is correct, control of bacterial vaginosis could reduce HIV-1 transmission.
体外研究表明,细菌性阴道病可能会增加人类免疫缺陷病毒1型(HIV-1)在生殖道中的存活几率。因此,在对性活动及其他性传播疾病(STD)的存在情况进行校正之后,我们对HIV-1感染与包括细菌性阴道病和乳酸杆菌减少在内的阴道菌群异常之间的关联进行了调查。
在乌干达西南部拉凯区农村开展的以社区为基础的预防HIV-1性传播疾病控制试验的首轮调查中,我们选取了4718名年龄在15至59岁之间的女性。她们提供了访谈信息、用于HIV-1和梅毒血清学检测的血液、用于沙眼衣原体和淋病奈瑟菌检测的尿液,以及两份自行采集的阴道拭子,用于阴道毛滴虫培养和阴道菌群的革兰氏染色检测,并通过标准化的定量形态学评分进行分类。评分0至3表示阴道菌群正常(以乳酸杆菌为主)。分数越高表明革兰氏阴性厌氧菌取代了乳酸杆菌(4至6分为中度;7至8分和9至10分为中度和重度细菌性阴道病)。
阴道菌群正常的女性中HIV-1感染率为14.2%,患有严重细菌性阴道病的女性中该感染率为26.7%(p<0.0001)。我们发现细菌性阴道病与年轻女性中HIV-1感染增加有关,但40岁以上女性中无此关联;这种关联无法通过性活动差异或同时感染其他性传播疾病来解释。有症状的HIV-1感染女性(55.0%)和无症状的HIV-1感染女性(55.7%)中细菌性阴道病的发生率相似。与任何阴道菌群异常(评分4至10)相关的HIV-1感染校正比值比为1.52(95%可信区间1.22至1.90),中度细菌性阴道病(评分7至8)为1.50(1.18至1.89),重度细菌性阴道病(评分9至10)为2.08(1.48至2.94)。
这项横断面研究无法表明阴道菌群紊乱是否会增加对HIV-1感染的易感性。然而,在可能近期感染HIV-1的年轻女性中,HIV-1感染频率与菌群异常增加有关,但在可能较早感染HIV-1的老年女性中并非如此,这表明乳酸杆菌减少或细菌性阴道病的存在可能会增加感染HIV-1的易感性。如果这一推断正确,那么控制细菌性阴道病可能会减少HIV-1的传播。